CSIMarket
 
Sight Sciences Inc   (SGHT)
 

News about Sight Sciences Inc




Groundbreaking Results from The ROMEO Study: OMNI Surgery Achieves Remarkable Pressure ...
May 28 2024
Sight Sciences Announces Promising Results from The ROMEO Study: OMNI Shows Effective Reductions in Pressure and Medication Usage Across All Stages of...

Predicine Boosts Global Precision Medicine with PredicineCARE NGS Kit
Apr 12 2024
Precision medicine has emerged as a game-changer in the field of healthcare, providing tailored treatments for patients based on their genetic profile...

Large-Scale Study Shows the Effectiveness of Sight Sciences* OMNI Surgical System in Treating Glaucoma
Apr 10 2024
Sight Sciences, a leading medical technology company, has recently published a groundbreaking study demonstrating the efficacy of their OMNI Surgical ...

Evolving Ophthalmic Care: OMNI Surgical System Proves Effective for Glaucoma, TearCare Technology Provides Relief for Dry Eye Disease
Apr 02 2024
In a remarkable breakthrough for the field of ophthalmology, Sight Sciences showcased the remarkable results of their GEMINI Trial and the cross-over ...

Sight Sciences Launches Game-Changing ERGO-Series of OMNI Surgical System, Revamping Glaucoma Surgery at ESCRS Winter Meeting
Feb 14 2024
Sight Sciences Revolutionizes Glaucoma Surgery with European Launch of the Ergo-Series of the OMNI Surgical System at the ESCRS Winter MeetingMENLO PA...

Company X*s Strategic Refinancing Points Towards Financial Stability and Growth.
Jan 23 2024
Refinancing Replaces Prior Senior Credit Facility: A Step Towards Financial StabilityIn the ever-evolving landscape of finance, companies often n...

TearCare: A New Vision for Dry Eye Relief - Revolutionary Eyelid Interventions Prove Successful in Clinical Trial
Dec 18 2023
TearCare Eyelid Procedures Show Promising Results in Treating Dry Eye Disease: SAHARA Clinical Trial Reveals Significant ImprovementsIn a recent ...

Sustained IOP Reductions and Medication Reductions Demonstrated in Three-Year GEMINI 2 Trial - OMNI Surgical System Proves its Long-term Safety and Efficacy
Dec 08 2023
Sight Sciences, a leading medical device company, has recently made an exciting announcement regarding the acceptance for publication of GEMINI 2...

Sight Sciences Inc*s Future Shines Bright as Investors Thrive on Promising Results
Nov 08 2023
Investors Optimistic About Sight Sciences Inc*s Future PerformanceSight Sciences Inc, a leading medical equipment and supplies company, has shown...

Evanescence of Losses at the Medical Equipment & Supplies company all along the second quarter of 2023
Aug 08 2023
Sight Sciences Inc, a medical equipment and supplies company, has shown impressive performance in the second quarter of 2023 when compared to the same...

Sight Sciences Inc Struggles to Achieve Profitability Despite Impressive Revenue Surge in First Quarter of 2023
May 09 2023
The stock market can be a tricky place to navigate, and when it comes to investing in companies, it is essential to conduct thorough research before m...


May 09 2023
...

Sight Sciences Inc declared an exceptional outcome, in the most recent fiscal period
May 09 2023
...

A loss of $-0.49 per Share at the Sight Sciences Inc in fiscal first quarter of 2022
May 09 2023
...

Observing the fourth quarter of 2021 numbers, SGHTs* had
May 09 2023
...









Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com